{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:35:44Z","timestamp":1794854144793,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["960881"],"award-info":[{"award-number":["960881"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In this study redox-sensitive (RS) liposomes manufactured using 10,10\u2032-diselanediylbis decanoic acid (DDA), an organoselenium RS compound, to enhance the therapeutic performance of doxorubicin (Dox). The DDA structure was confirmed by 1H NMR and LC\u2013MS\/MS. Various liposomal formulations (33 formulations) were prepared using DOPE, Egg PC, and DOPC with Tm\u00a0\u02c2\u00a00 and DDA. Some formulations had mPEG\n                    <jats:sub>2000<\/jats:sub>\n                    -DSPE and cholesterol. After extrusion, the external phase was exchanged with sodium bicarbonate to create a pH gradient. Then, Dox was remotely loaded into liposomes. The optimum formulations indicated a burst release of 30% in the presence of 0.1% hydrogen peroxide at pH 6.5, thanks to the redox-sensitive role of DDA moieties; conversely, Caelyx (PEGylated liposomal Dox) showed negligible release at this condition. RS liposomes consisting of DOPE\/Egg PC\/DDA at 37.5 \/60\/2.5% molar ratio, efficiently inhibited C26 tumors among other formulations. The release of Dox from RS liposomes in the TME through the DDA link fracture triggered by ROS or glutathione is seemingly the prerequisite for the formulations to exert their therapeutic action. These findings suggest the potential application of such intelligent formulations in the treatment of various malignancies where the TME redox feature could be exploited to achieve an improved therapeutic response.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-15239-x","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T13:07:05Z","timestamp":1656940025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy"],"prefix":"10.1038","volume":"12","author":[{"given":"Elaheh","family":"Mirhadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mashreghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Askarizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Mehrabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Hoda","family":"Alavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Badiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"issue":"2","key":"15239_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000265166","volume":"115","author":"K Chatterjee","year":"2010","unstructured":"Chatterjee, K. et al. Doxorubicin cardiomyopathy. Cardiology 115(2), 155\u2013162 (2010).","journal-title":"Cardiology"},{"issue":"1","key":"15239_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2045-080X.174930","volume":"7","author":"YH Ngan","year":"2016","unstructured":"Ngan, Y. H. & Gupta, M. A comparison between liposomal and nonliposomal formulations of doxorubicin in the treatment of cancer: An updated review. Arch. Pharm. Pract. 7(1), 1 (2016).","journal-title":"Arch. Pharm. Pract."},{"issue":"4","key":"15239_CR3","first-page":"567","volume":"2","author":"AM Rahman","year":"2007","unstructured":"Rahman, A. M., Yusuf, S. W. & Ewer, M. S. Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int. J. Nanomed. 2(4), 567 (2007).","journal-title":"Int. J. Nanomed."},{"issue":"45","key":"15239_CR4","doi-asserted-by":"publisher","first-page":"16649","DOI":"10.1073\/pnas.0607705103","volume":"103","author":"CC Lee","year":"2006","unstructured":"Lee, C. C. et al. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc. Natl. Acad. Sci. 103(45), 16649\u201316654 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"15239_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4172\/2157-7439.1000519","volume":"9","author":"N Zhao","year":"2018","unstructured":"Zhao, N., Woodle, M. C., Mixson A. J. Advances in delivery systems for doxorubicin. J. Nanomed. Nanotechnol. 9(5), 915 (2018)","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"5","key":"15239_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092555","volume":"9","author":"AV Andriyanov","year":"2014","unstructured":"Andriyanov, A. V. et al. Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: Comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes. PLoS\u00a0One 9(5), e92555 (2014).","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"15239_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jconrel.2013.02.026","volume":"168","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y. et al. A simple way to enhance Doxil\u00ae therapy: Drug release from liposomes at the tumor site by amphiphilic block copolymer. J. Control. Release 168(1), 61\u201369 (2013).","journal-title":"J. Control. Release"},{"key":"15239_CR8","doi-asserted-by":"crossref","unstructured":"Torchilin, V. P. Passive and active drug targeting: Drug delivery to tumors as an example. Drug Deliv. (197), 3\u201353 (2010).","DOI":"10.1007\/978-3-642-00477-3_1"},{"issue":"2","key":"15239_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"YC Barenholz","year":"2012","unstructured":"Barenholz, Y. C. Doxil\u00ae\u2014The first FDA-approved nano-drug: Lessons learned. J. Control. Release 160(2), 117\u2013134 (2012).","journal-title":"J. Control. Release"},{"issue":"10","key":"15239_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025721","volume":"6","author":"Y Avnir","year":"2011","unstructured":"Avnir, Y. et al. Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids. PLoS\u00a0One 6(10), e25721 (2011).","journal-title":"PLoS\u00a0One"},{"issue":"7","key":"15239_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jvir.2013.03.006","volume":"24","author":"M Moussa","year":"2013","unstructured":"Moussa, M. et al. Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature. J. Vasc. Interv. Radiol. 24(7), 1021\u20131033 (2013).","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"4","key":"15239_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00003495-199700544-00005","volume":"54","author":"A Gabizon","year":"1997","unstructured":"Gabizon, A. & Martin, F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Drugs 54(4), 15\u201321 (1997).","journal-title":"Drugs"},{"key":"15239_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jconrel.2020.08.012","volume":"327","author":"FM Kashkooli","year":"2020","unstructured":"Kashkooli, F. M., Soltani, M. & Souri, M. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. J. Control. Release 327, 316\u2013349 (2020).","journal-title":"J. Control. Release"},{"issue":"7","key":"15239_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/pharmaceutics12070630","volume":"12","author":"SH Pham","year":"2020","unstructured":"Pham, S. H., Choi, Y. & Choi, J. Stimuli-responsive nanomaterials for application in antitumor therapy and drug delivery. Pharmaceutics 12(7), 630 (2020).","journal-title":"Pharmaceutics"},{"key":"15239_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jconrel.2020.03.051","volume":"322","author":"F Li","year":"2020","unstructured":"Li, F. et al. Stimuli-responsive nano-assemblies for remotely controlled drug delivery. J. Control. Release 322, 566\u2013592 (2020).","journal-title":"J. Control. Release"},{"issue":"1","key":"15239_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1527","volume":"11","author":"Y Qiao","year":"2019","unstructured":"Qiao, Y. et al. Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 11(1), e1527 (2019).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"5","key":"15239_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1450","volume":"9","author":"Y Lee","year":"2017","unstructured":"Lee, Y. & Thompson, D. Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 9(5), e1450 (2017).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"15239_CR18","doi-asserted-by":"publisher","first-page":"119882","DOI":"10.1016\/j.ijpharm.2020.119882","volume":"589","author":"E Mirhadi","year":"2020","unstructured":"Mirhadi, E. et al. Redox-sensitive nanoscale drug delivery systems for cancer treatment. Int. J. Pharm. 589, 119882 (2020).","journal-title":"Int. J. Pharm."},{"key":"15239_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev-anchem-062011-143157","volume":"5","author":"RL McCarley","year":"2012","unstructured":"McCarley, R. L. Redox-responsive delivery systems. Annu. Rev. Anal. Chem. 5, 391\u2013411 (2012).","journal-title":"Annu. Rev. Anal. Chem."},{"key":"15239_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.sbi.2019.03.001","volume":"59","author":"F Magnani","year":"2019","unstructured":"Magnani, F. & Mattevi, A. Structure and mechanisms of ROS generation by NADPH oxidases. Curr. Opin. Struct. Biol. 59, 91\u201397 (2019).","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"15239_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40828-019-0101-8","volume":"6","author":"CC Winterbourn","year":"2020","unstructured":"Winterbourn, C. C. Biological chemistry of superoxide radicals. ChemTexts 6(1), 1\u201313 (2020).","journal-title":"ChemTexts"},{"key":"15239_CR22","doi-asserted-by":"publisher","unstructured":"Patel, R. et al. Reactive oxygen species: The good and the bad. In Reactive Oxygen Species (ROS) in Living Cells (2018). https:\/\/doi.org\/10.5772\/intechopen.71547","DOI":"10.5772\/intechopen.71547"},{"issue":"12","key":"15239_CR23","doi-asserted-by":"publisher","first-page":"S498","DOI":"10.1097\/01.CCM.0000186787.64500.12","volume":"33","author":"H Bayr","year":"2005","unstructured":"Bayr, H. Reactive oxygen species. Crit. Care Med. 33(12), S498\u2013S501 (2005).","journal-title":"Crit. Care Med."},{"issue":"8","key":"15239_CR24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/cancers11081191","volume":"11","author":"F Weinberg","year":"2019","unstructured":"Weinberg, F., Ramnath, N. & Nagrath, D. Reactive oxygen species in the tumor microenvironment: An overview. Cancers 11(8), 1191 (2019).","journal-title":"Cancers"},{"issue":"1","key":"15239_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/ijms20010075","volume":"20","author":"HW Tan","year":"2018","unstructured":"Tan, H. W. et al. Selenium species: Current status and potentials in cancer prevention and therapy. Int. J. Mol. Sci. 20(1), 75 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"15239_CR26","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1158\/1078-0432.CCR-03-0268","volume":"10","author":"S Cao","year":"2004","unstructured":"Cao, S., Durrani, F. A. & Rustum, Y. M. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin. Cancer Res. 10(7), 2561\u20132569 (2004).","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"15239_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1021\/ja908124g","volume":"132","author":"N Ma","year":"2010","unstructured":"Ma, N. et al. Dual redox responsive assemblies formed from diselenide block copolymers. J. Am. Chem. Soc. 132(2), 442\u2013443 (2010).","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"15239_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijpharm.2018.05.056","volume":"548","author":"F Behroozi","year":"2018","unstructured":"Behroozi, F. et al. Smart liposomal drug delivery for treatment of oxidative stress model in human embryonic stem cell-derived retinal pigment epithelial cells. Int. J. Pharm. 548(1), 62\u201372 (2018).","journal-title":"Int. J. Pharm."},{"issue":"9","key":"15239_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10856-015-5573-5","volume":"26","author":"X Zeng","year":"2015","unstructured":"Zeng, X. et al. Redox poly (ethylene glycol)-b-poly (l-lactide) micelles containing diselenide bonds for effective drug delivery. J. Mater. Sci. Mater. Med. 26(9), 1\u201312 (2015).","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"31","key":"15239_CR30","doi-asserted-by":"publisher","first-page":"7765","DOI":"10.1016\/j.biomaterials.2012.07.003","volume":"33","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. Hyperbranched polydiselenide as a self assembling broad spectrum anticancer agent. Biomaterials 33(31), 7765\u20137774 (2012).","journal-title":"Biomaterials"},{"issue":"19","key":"15239_CR31","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1021\/la501054z","volume":"30","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. Dual redox responsive coassemblies of diselenide-containing block copolymers and polymer lipids. Langmuir 30(19), 5628\u20135636 (2014).","journal-title":"Langmuir"},{"issue":"5","key":"15239_CR32","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1021\/bm4002574","volume":"14","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Therapeutic nanocarriers with hydrogen peroxide-triggered drug release for cancer treatment. Biomacromol 14(5), 1627\u20131636 (2013).","journal-title":"Biomacromol"},{"key":"15239_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-9776(01)80001-1","volume":"10","author":"C Swenson","year":"2001","unstructured":"Swenson, C. et al. Liposome technology and the development of Myocet\u2122(liposomal doxorubicin citrate). Breast 10, 1\u20137 (2001).","journal-title":"Breast"},{"issue":"17","key":"15239_CR34","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2217\/nnm.15.108","volume":"10","author":"KS Kim","year":"2015","unstructured":"Kim, K. S. et al. Reactive oxygen species-activated nanomaterials as theranostic agents. Nanomedicine 10(17), 2709\u20132723 (2015).","journal-title":"Nanomedicine"},{"issue":"8","key":"15239_CR35","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.bbamem.2006.02.015","volume":"1758","author":"GP Bienert","year":"2006","unstructured":"Bienert, G. P., Schjoerring, J. K. & Jahn, T. P. Membrane transport of hydrogen peroxide. Biochim. Biophys. Acta BBA Biomembr. 1758(8), 994\u20131003 (2006).","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"issue":"2","key":"15239_CR36","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1074\/jbc.M603761200","volume":"282","author":"GP Bienert","year":"2007","unstructured":"Bienert, G. P. et al. Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J. Biol. Chem. 282(2), 1183\u20131192 (2007).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"15239_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4155\/tde.11.13","volume":"2","author":"L Xu","year":"2011","unstructured":"Xu, L., Wempe, M. F. & Anchordoquy, T. J. The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro. Ther. Deliv. 2(4), 451\u2013460 (2011).","journal-title":"Ther. Deliv."},{"key":"15239_CR38","doi-asserted-by":"publisher","first-page":"705886","DOI":"10.3389\/fbioe.2021.705886","volume":"9","author":"P Nakhaei","year":"2021","unstructured":"Nakhaei, P. et al. Liposomes: Structure, biomedical applications, and stability parameters with emphasis on cholesterol. Front. Bioeng. Biotechnol. 9, 705886 (2021).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"10","key":"15239_CR39","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.bbamem.2006.05.028","volume":"1758","author":"A Fritze","year":"2006","unstructured":"Fritze, A. et al. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim. Biophys. Acta BBA Biomembr. 1758(10), 1633\u20131640 (2006).","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"issue":"1","key":"15239_CR40","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1021\/nn304474j","volume":"7","author":"K-J Chen","year":"2013","unstructured":"Chen, K.-J. et al. A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery. ACS Nano 7(1), 438\u2013446 (2013).","journal-title":"ACS Nano"},{"issue":"4","key":"15239_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ajps.2018.07.006","volume":"14","author":"H Bi","year":"2019","unstructured":"Bi, H. et al. Current developments in drug delivery with thermosensitive liposomes. Asian J. Pharm. Sci. 14(4), 365\u2013379 (2019).","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"15239_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0047-6374(86)90028-X","volume":"33","author":"SI Carlile","year":"1986","unstructured":"Carlile, S. I. et al. Age-related changes in the rate of esterification of plasma cholesterol in Fischer-344 rats. Mech. Ageing Dev. 33(2), 211\u2013220 (1986).","journal-title":"Mech. Ageing Dev."},{"issue":"1\u20132","key":"15239_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molcata.2005.03.005","volume":"234","author":"T Joseph","year":"2005","unstructured":"Joseph, T., Sahoo, S. & Halligudi, S. Br\u00f6nsted acidic ionic liquids: A green, efficient and reusable catalyst system and reaction medium for Fischer esterification. J. Mol. Catal. A Chem. 234(1\u20132), 107\u2013110 (2005).","journal-title":"J. Mol. Catal. A Chem."},{"issue":"1","key":"15239_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/molecules23010095","volume":"23","author":"S-F Chang","year":"2018","unstructured":"Chang, S.-F. et al. The impact of lipid types and liposomal formulations on osteoblast adiposity and mineralization. Molecules 23(1), 95 (2018).","journal-title":"Molecules"},{"issue":"1","key":"15239_CR45","first-page":"29","volume":"27","author":"LP Tseng","year":"2007","unstructured":"Tseng, L. P. et al. Liposomes incorporated with cholesterol for drug release triggered by magnetic field. J. Med. Biol. Eng. 27(1), 29\u201334 (2007).","journal-title":"J. Med. Biol. Eng."},{"issue":"7","key":"15239_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/pharmaceutics13070973","volume":"13","author":"MC Garc\u00eda","year":"2021","unstructured":"Garc\u00eda, M. C. et al. Cholesterol levels affect the performance of AuNPs-decorated thermo-sensitive liposomes as nanocarriers for controlled doxorubicin delivery. Pharmaceutics 13(7), 973 (2021).","journal-title":"Pharmaceutics"},{"key":"15239_CR47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ajps.2020.07.005","volume":"16","author":"J Di","year":"2020","unstructured":"Di, J. et al. Size, shape, charge and \u201cstealthy\u201d surface: Carrier properties affect the drug circulation time in vivo. Asian J. Pharm. Sci. 16, 444\u2013458 (2020).","journal-title":"Asian J. Pharm. Sci."},{"issue":"9","key":"15239_CR48","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33(9), 941\u2013951 (2015).","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"15239_CR49","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.3390\/molecules200610095","volume":"20","author":"J Rafique","year":"2015","unstructured":"Rafique, J. et al. Synthesis and biological evaluation of 2-picolylamide-based diselenides with non-bonded interactions. Molecules 20(6), 10095\u201310109 (2015).","journal-title":"Molecules"},{"key":"15239_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-6591-5_2","volume-title":"Liposomes","author":"H Zhang","year":"2017","unstructured":"Zhang, H. Thin-film hydration followed by extrusion method for liposome preparation. In Liposomes 17\u201322 (Springer, 2017)."},{"issue":"3","key":"15239_CR51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","volume":"234","author":"GR Bartlett","year":"1959","unstructured":"Bartlett, G. R. Phosphorus assay in column chromatography. J. Biol. Chem. 234(3), 466\u2013468 (1959).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"15239_CR52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/1061186X.2020.1870230","volume":"29","author":"M Mashreghi","year":"2021","unstructured":"Mashreghi, M. et al. Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide. J. Drug Target. 29(6), 617\u2013630 (2021).","journal-title":"J. Drug Target."},{"issue":"6","key":"15239_CR53","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1128\/AAC.01319-08","volume":"53","author":"MR Jaafari","year":"2009","unstructured":"Jaafari, M. R. et al. Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB\/c mice. Antimicrob. Agents Chemother. 53(6), 2259\u20132265 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"15239_CR54","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.2174\/1871520621666210217095627","volume":"21","author":"M Hatamipour","year":"2021","unstructured":"Hatamipour, M. et al. Anti-tumor efficacy of pyrvinium pamoate nanoliposomes in an experimental model of melanoma. Anti-Cancer Agents Med. Chem. 21, 2379\u20132384 (2021).","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"12","key":"15239_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003951","volume":"3","author":"D-H Yu","year":"2008","unstructured":"Yu, D.-H. et al. Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy. PLoS\u00a0One 3(12), e3951 (2008).","journal-title":"PLoS\u00a0One"},{"key":"15239_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jconrel.2015.10.044","volume":"220","author":"L Arabi","year":"2015","unstructured":"Arabi, L. et al. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin. J. Control. Release 220, 275\u2013286 (2015).","journal-title":"J. Control. Release"},{"issue":"2","key":"15239_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0005-2736(92)90084-Y","volume":"1109","author":"AT Horowitz","year":"1992","unstructured":"Horowitz, A. T., Barenholz, Y. & Gabizon, A. A. In vitro cytotoxicity of liposome-encapsulated doxorubicin: Dependence on liposome composition and drug release. Biochim. Biophys. Acta BBA Biomembr. 1109(2), 203\u2013209 (1992).","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"issue":"1","key":"15239_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11671-020-03334-9","volume":"15","author":"M Mashreghi","year":"2020","unstructured":"Mashreghi, M. et al. Anti-Epcam aptamer (Syl3c)-functionalized liposome for targeted delivery of doxorubicin: In vitro and in vivo antitumor studies in mice bearing C26 colon carcinoma. Nanoscale Res. Lett. 15(1), 1\u201313 (2020).","journal-title":"Nanoscale Res. Lett."},{"key":"15239_CR59","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.toxrep.2015.08.002","volume":"2","author":"SM Chacko","year":"2015","unstructured":"Chacko, S. M. et al. Protective effect of p-coumaric acid against doxorubicin induced toxicity in H9c2 cardiomyoblast cell lines. Toxicol. Rep. 2, 1213\u20131221 (2015).","journal-title":"Toxicol. Rep."},{"issue":"9","key":"15239_CR60","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1177\/0271678X20943823","volume":"40","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. J. Cereb. Blood Flow Metab. 40(9), 1769\u20131777 (2020).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"15239_CR61","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jconrel.2017.06.027","volume":"261","author":"Y Chi","year":"2017","unstructured":"Chi, Y. et al. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. J. Control. Release 261, 113\u2013125 (2017).","journal-title":"J. Control. Release"},{"key":"15239_CR62","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.colsurfb.2015.12.009","volume":"139","author":"SA Moosavian","year":"2016","unstructured":"Moosavian, S. A. et al. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Colloids Surf. B 139, 228\u2013236 (2016).","journal-title":"Colloids Surf. B"},{"issue":"2","key":"15239_CR63","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ijpharm.2013.10.018","volume":"458","author":"M Amin","year":"2013","unstructured":"Amin, M., Badiee, A. & Jaafari, M. R. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas. Int. J. Pharm. 458(2), 324\u2013333 (2013).","journal-title":"Int. J. Pharm."},{"issue":"5","key":"15239_CR64","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1158\/1078-0432.CCR-05-1566","volume":"12","author":"T Schluep","year":"2006","unstructured":"Schluep, T. et al. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models. Clin. Cancer Res. 12(5), 1606\u20131614 (2006).","journal-title":"Clin. Cancer Res."},{"key":"15239_CR65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejca.2020.01.010","volume":"129","author":"P Zamani","year":"2020","unstructured":"Zamani, P. et al. Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer. Eur. J. Cancer 129, 80\u201396 (2020).","journal-title":"Eur. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15239-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:14:09Z","timestamp":1669338849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15239"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15239-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"12 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11310"}}